baber/WOPTO huggingface dataset:
Patent DE-69104188-D1 (DE)
Inventor: REIGNIER MARIANNE
IPC: C23F3/06
Filed: 1991-02-18
Granted: 1994-10-27
Abstract: Baths for chemically polishing stainless steel surfaces comprising, in an aqueous solution, a mixture of hydrochloric acid, nitric acid and phosphoric acid, an optionally substituted hydroxybenzoic acid, an abietic compound and an additive selected from perchloric acid and the water-soluble salts thereof.
Patent DE-69110902-D1 (DE)
Inventor: NAPARI JUKKA
IPC: C04B40/02
Filed: 1991-10-31
Granted: 1995-08-03
Abstract: The invention concerns a drying procedure for non-destructive drying out of wet structures on concrete, stone, brick and/or block base, wherein on the surface (2) of the object to be dried (1) is directed dewatering radiation. As taught by the invention, microwaves are used for radiation.
Patent DE-69112673-D1 (DE)
Inventor: CARENINI GIOVANNI PIETRO
IPC: D06F57/08
Filed: 1991-02-04
Granted: 1995-10-12
Abstract: The invention discloses a joint for connecting two tubes which fold one on the other, in particular for connecting tubes which form the folding legs of a clothes-horse. The joint is formed of a body (10) having on one side a part with a hole (11) open at least towards one end of the body and designed to hold one end of the elements (13) to be connected and, on the other side, a U-shaped part which delimits a channel (12) which is open on one side of said body and designed to hold an end of the other element (14) to be connected, the end of the first element (13) being blocked in said hole (12) whilst the second element (14) is pivoted (14a) in said channel so as to be foldable on the first element. <IMAGE>
Patent DE-69112989-D1 (DE)
Inventor: AONO TETSUYA
IPC: C07D521/00
Filed: 1991-10-29
Granted: 1995-10-19
Abstract: A novel aminocoumaran derivatives of the general formula (I): <CHEM> wherein R<1> and R<2> are a hydrogen atom, an acyl group, an alkoxycarbonyl group, an aliphatic group or aromatic group; R<3>, R<4> and R<5> are an optionally acylated hydroxyl, optionally substituted amino group, alkoxy group or aliphatic group, or two of R<3>, R<4> and R<5> may be linked together to form a carbocyclic group; R<6> and R<7> are an aliphatic group and at least one of them has a methylene group at the  alpha -position; R<8> and R<9> are a hydrogen atom or an aliphatic group or aromatic group, or a salt thereof is useful for medicines for preventing and treating various diseases such as arterial sclerosis, hepatopathy, cerebrovascular diseases and the like.
Patent DE-69116988-D1 (DE)
Inventor: YOSHIMURA HIROYUKI
IPC: C07C45/00
Filed: 1991-11-14
Granted: 1996-03-21
Abstract: The present invention concerns naphthalene derivatives of the formula: <CHEM> with specific meanings for the substituents R<1> to R<4> and Y and Z. The above compounds are useful as medicaments for the treating of diseases resulting in an increased production of prostaglandin or leukotrines, for treating an inflammatory disease and for treating a disease selected from chronic rheumatoid arthritis, osteoarthritis, shoulder periarthritis, cervicobrachial syndrome and lumbago.
Patent DE-69121222-D1 (DE)
Inventor: DEMAREZ PHILIPPE
IPC: B22D11/124
Filed: 1991-08-06
Granted: 1996-09-12
Abstract: According to this method, the metal is solidified in a continuous-casting ingot mould consisting of two cooled rolls (2) rotating in opposite directions and arranged opposite each other so as to define a casting space between them, a solidified steel strip (3) is extracted continuously from the ingot mould, and, under the ingot mould, the said strip is subjected to a quenching medium (6) in order to cool it sufficiently rapidly in order to prevent the formation of austenite. This medium may consist of a quenching bath, placed in a container (4) arranged under the rolls (2), and whose bottom is pierced with an opening (5) for the passage of the solidified strip (3). It may also consist of an inert gas in the liquid state sprayed onto the product by nozzles. The steel strips obtained are easier to trim and to coil on exit from the casting line, by virtue of the absence of martensite in the ferritic matrix. 
<IMAGE>
Patent DE-69122892-D1 (DE)
Inventor: ICHINOSE TOSHIMITSU
IPC: B01D53/81
Filed: 1991-11-27
Granted: 1996-11-28
Abstract: In a method and apparatus for desulfurizing exhaust gas, wherein combustion furnace desulfurization and flue desulfurization by means of limestone are effected, a desulfurization rate is enhanced, a dust precipitator is operated stably, and generation of harmful substance (CaSO3) is suppressed. The present invention proposed a method for desulfurizing exhaust gas, wherein desulfurizing operations within a combustion furnace and within an exhaust gas flue by means of limestone are combined. The method is characterized in that after fly ash produced after desulfurization within the exhaust gas flue serving as a desulfurizing flue was collected, a part or whole of the fly ash is again charged into a high-temperature section within the combustion furnace , collection of the fly ash is carried out at the outlet of the combustion furnace and at the upper stream of the desulfurizing flue, an effective component part of said collected fly ash is used as a desulfurizing agent within the desulfurizing flue , and the remainder publicly harmless component part is abandoned to the outside of the system. <IMAGE>
Patent DE-69123881-D1 (DE)
Inventor: FUSSELMAN DAVID FRANCIS
IPC: H01R12/50
Filed: 1991-06-10
Granted: 1997-02-13
Abstract: The present invention relates to an electrical connector with a ground structure for impedance and cross talk control between signal carrying conductors such as a circuit (224) and a connector (400) having first contacts (435) and second side contacts (465). In particular, a right angle or angled connector (200) comprising an insulative housing (230) having side walls (230) and a plurality of passages in rows and columns within the side walls. The connector further comprises a first plurality of contact elements (235), each element having a third and fourth (255) contact, the third contacts arranged for contacting the first contacts (435) and the fourth contacts (255) extending at an angle to the third contacts (235). The connector further comprises a conductor (240) arranged on a side wall (230) having a fifth contacts (265) for contacting the second side contacts (465) of the second connector (400) and a sixth contacts (275) for contacting a conductive shield (300), the shield having contacts (315) positioned in rows and columns with the fourth contacts (255) for connection to the circuit (224). <IMAGE>
Patent DE-69128478-D1 (DE)
Inventor: FORSBERG ERIK
IPC: H01F27/28
Filed: 1991-07-01
Granted: 1998-01-29
Abstract: PCT No. PCT/SE91/00471 Sec. 371 Date Jan. 6, 1993 Sec. 102(e) Date Jan. 6, 1993 PCT Filed Jul. 1, 1991 PCT Pub. No. WO92/02941 PCT Pub. Date Feb. 20, 1992.A procedure when joining the tail ends of sheet-wound coils stacked one on top of the other around an inductive apparatus core with a certain axial space between them, the joint being effected using a thin leader strip which is connected to adjacent parts of the coils and joined to the coils along almost one coil turn.
Patent DE-69213214-D1 (DE)
Inventor: WALLIS ROGER
IPC: B22D41/14
Filed: 1992-01-14
Granted: 1996-10-02
Abstract: PCT No. PCT/GB92/00080 Sec. 371 Date Jul. 6, 1993 Sec. 102(e) Date Jul. 6, 1993 PCT Filed Jan. 14, 1992 PCT Pub. No. WO92/12815 PCT Pub. Date Aug. 6, 1992A rotary valve for use in the release of a molten solid from a vessel comprises a valve member having a passage, inlets to the passage being present in the head of the member. The valve member mates with a wall of a seating member, the wall having a taller first section and a lower second section selected to close off or open the inlets, respectively. The wall portions are shaped relative to the surfaces of the member to avoid metal freezing and the parts sticking. The passage includes ribs to cause the stream to emerge with parallel sides.
Patent DE-69232825-D1 (DE)
Inventor: PELOSI JR
IPC: C07D405/12
Filed: 1992-08-10
Granted: 2002-11-21
Abstract: The novel cyclic ureas of the present invention are useful as antiarrhythmic and antifibrillatory agents and have general structure (I) <CHEM> wherein (a) X is a saturated or unsaturated, 5-, 6-, or 7-membered heterocycle or carbocycle; (b) R is selected from the group consisting of covalent bond, nil, heteroatom, carbonyl, heterocyclic ring, carbocyclic ring, alkyl, alkenyl, alkoxy, alkylamino, arylalkyl, aryloxy, acyl, acyloxy, and acylamino; (c) Y is a substituted or unsubstituted, saturated or unsaturated, 5-, 6-, or 7-membered heterocyclic ring or carbocyclic ring, or is nil; and wherein when R is nil, X and Y are fused ring systems; and when R is a covalent bond, X and Y are ring systems linked through a covalent bond; and when Y is nil, R is a covalent bond and X is bound to L through R; (d) R1, R2 and R3 are independently selected from the group consisting of nil, Cl, F, Br, NH2, CF3, OH, SO3H, CH3SO2NH, COOH, alkoxy, alkyl, alkoxycarbonyl, hydroxyalkyl, carboxyalkyl, aminoalkyl, acylamino, and acyloxy; (e) L is selected from the group consisting of alkylamino, alkenylamino, alkylimino, alkenylimino, and acylamino wherein the nitrogen atom thereof is bound to the nitrogen atom at the 1-position of the cyclic urea moiety; (f) R4 is selected from the group consisting of alkyl, alkenyl, alkynyl, alkylacyl, and heteroalkyl; (g) A is a substituted or unsubstituted, saturated or unsaturated, straight-chain or branched, C1-C8 heteroalkyl, or a substituted or unsubstituted, saturated or unsaturated heterocycle having 5-, 6-, or 7-members; and has one nitrogen atom, which is adjacent to R4; and (h) R5 is a substituted or unsubstituted C2 alkylene; and pharmaceutically-acceptable salts and esters thereof.
Patent DE-69300255-D1 (DE)
Inventor: CARCELLER ELENA
IPC: A61P9/10
Filed: 1993-05-19
Granted: 1995-08-17
Abstract: The present invention relates to 8-chloro-11-[1-[(5-methyl-3-pyridyl)methyl]-4-piperidyliden]-6,11-dihy dro-5H- benzo[5,6]cyclohepta[1,2-b]pyridine, to a process for its preparation and to pharmaceutical compositions containing it. This compound is a dual PAF antagonist and antihistamine.
Patent DE-69311708-D1 (DE)
Inventor: KJAER BJARNE
IPC: A23C19/068
Filed: 1993-04-07
Granted: 1997-07-24
Abstract: PCT No. PCT/DK93/00131 Sec. 371 Date Dec. 16, 1994 Sec. 102(e) Date Dec. 16, 1994 PCT Filed Apr. 7, 1993 PCT Pub. No. WO93/20704 PCT Pub. Date Oct. 28, 1993A method of cheese production using ultrafiltrated, concentrated milk, to which is optionally added a further retentate made from ultrafiltrated milk which has been acidified with at least one starter culture to obtain a pH value of from 4.5 to 5.6. Salt and other additives are added and while supplying cheese rennet, the retentate is pumped into cheese molds or ready-made packages in which the cheese receives a final heat treatment at from 18 DEG  to 65 DEG  C. for a period of from 4 to 36 hours.
Patent DE-69317436-D1 (DE)
Inventor: HOUSLEY JOHN ROSINDALE
IPC: C07D281/10
Filed: 1993-11-06
Granted: 1998-04-16
Abstract: PCT No. PCT/EP93/03123 Sec. 371 Date May 3, 1995 Sec. 102(e) Date May 3, 1995 PCT Filed Nov. 6, 1993 PCT Pub. No. WO94/11360 PCT Pub. Date May 26, 1994Compounds of formula I    <IMAGE>  I  in which n=0, 1 or 2; R1, R2, R6 and R7 independently represent H or alkyl (optionally substituted by one or more halo); R3 and R4 independently represent H or alkyl or together represent a group of formula =NR12 where R12 represents H, hydroxy, alkyl, phenyl or alkoxy; each alkyl, phenyl and alkoxy being optionally substituted with one or more halo; R5 represents: (a) H, (b) alkyl, (c) a group of formula -COR13 in which R13 is H, alkyl or phenyl, when R3 and R4 represent H or alkyl (optionally substituted with one or more halo), or (d) a group of formula -S(O)pR14 in which p=1 or 2 and R14 is alkyl or phenyl, when R3 and R4 represent H or alkyl (optionally substituted with one or more halo); each alkyl and phenyl optionally substituted with one or more halo; and R8 to R11 independently represent H, halo, cyano, nitro, alkyl alkoxy, alkanoyl, carboxy, alkanoyloxy, carbamoyl (optionally substituted with alkyl or sulphamoyl (optionally substituted with alkyl of 1 to 4 carbon atoms); each alkyl, alkoxy, alkanoyl or alkanoyloxy optionally substituted with one or more halo; have utility in the treatment of seizures and/or neurological disorders such as epilepsy and/or as neuroprotective agents to protect against conditions such as stroke.
Patent DE-69318207-D1 (DE)
Inventor: CERNON ROBERT
IPC: G01J1/42
Filed: 1993-02-24
Granted: 1998-06-04
Abstract: The present invention relates to apparatus for in-situ evaluation of the light flux of narrow and intense light beams, in particular those from the beacon lights of airport runways and taxiways. It comprises a closed box mounted in a pod placed on a moving chassis, the box has a translucent front face that diffuses the light flux from the beam to be measured omni-directionally inside the box, and another face having high diffusing reflection power that closes the box and provides both reflection and diffusion of the light in uniform manner towards a photoelectric sensor whose sensitive portion is disposed close to the front face, but facing said diffusing reflection face.
Patent DE-69322272-D1 (DE)
Inventor: GRIFFITH OWEN W
IPC: C07C279/36
Filed: 1993-05-19
Granted: 1999-01-07
Abstract: Guanidino substituted arginines or homoarginines based on monoalkyl carbon-substituted ornithines or lysines, having the formula   <IMAGE>   wherein R is (CH2)yCH3 or H, R' is CH2 or C(H)(CH2)yCH3, and R'' is CH2 or C(H)(CH2)yCH3, with y ranging from 0 to 5, and x is 0 or 1 and Q is an alkyl group containing from 1 to 6 carbon atoms or NH2 or NO2, and only one of R, R' and R'' providing an alkyl substituent on the ornithine or lysine moiety. Preferred compounds are  alpha -methyl-N omega -methyl-DL-arginine, RS- beta -methyl-N omega -methyl-DL-arginine, RS- gamma -methyl-N omega -methyl-DL-arginine,  alpha -methyl-N omega -amino-DL-arginine, RS- beta -methyl-N omega -amino-DL-arginine, RS- gamma -methyl-N omega -amino-DL-arginine,  alpha -methyl-N omega -nitro-DL-arginine, RS- beta -methyl-N omega -nitro-DL-arginine, and RS- gamma -methyl-N omega -nitro-DL-arginine. A composition includes said compound together with a pharmaceutically acceptable carrier. Methods of use are directed to delivering said compound to inducible nitric oxide synthase to inhibit the ability of the enzyme to catalyze the conversion of arginine to nitric oxide, to administering said compound to inhibit pathological overproduction of nitric oxide from arginine and to administering said compound to a subject having systemic hypotension due to the pathological overproduction of nitric oxide and an  alpha 1 adrenergic agonist to increase blood pressure in the subject to a clinically acceptable level.
Patent DE-69328772-D1 (DE)
Inventor: YOUNG CAROLE
IPC: G01N33/49
Filed: 1993-02-17
Granted: 2000-07-06
Abstract: A hematology control product comprising leukocyte analogs and an aqueous solution of a plasma substance for use in a blood counting instrument is described. The instrument employs a lytic reagent system for the lysable red blood cells in the control product. The plasma substance is in an amount effective to enable the differentiation of each of said leukocyte analogs relative to the physical attributes of the analogs, said physical attributes of the analog are similar to human leukocytes. Preferably, the plasma substance comprises cholesterol or its derivatives. A method for using the cell suspension media comprising an aqueous solution of a plasma substance is also described. The method provides a quality control to determine whether an instrument is operating within manufacturer's specifications.
Patent DE-69407834-D1 (DE)
Inventor: RUGGIERI ROBERTO
IPC: C07C51/573
Filed: 1994-02-05
Granted: 1998-02-19
Abstract: In the purification of maleic anhydride obtained with an oxidation process, by means of absorption with an organic solvent and fractionation of the resulting liquid phase and purification of the crude maleic anhydride thus separated, the above purification being accomplished through two serially placed fractionating columns, the accumulation of polymerisable acrylic acid overhead the first fractionating column of the purification section, and of water as well as of maleic acid overhead the second fractionating column of the purification section, is avoided by carrying the overhead vapours of said first fractionating column to an absorption tower, preferably operating with the same absorption organic solvent used to absorb the crude maleic anhydride from the reaction mixture, and by carrying the overhead vapours of said fractionating column of said purification section to two condensers placed in series so that the gaseous fraction, coming out of the first condenser, is fed to said second condenser. <IMAGE>
Patent DE-69413357-D1 (DE)
Inventor: CALVERT BARRY GENE
IPC: B31B50/62
Filed: 1994-12-06
Granted: 1998-10-22
Abstract: The composite material package blank formed from a paperboard web has a barrier coating of a thermoplastics polymer film uniformly applied to an inside surface thereof and an outside surface of the paperboard web is printed with aqueous or solvent based inks and includes selectively positioned areas of a patterned solvent based polymer material applied to it. The paperboard web is folded about score lines to provide side walls integrally projected from a bottom panel. The side walls are laterally linked by integral gusset webs, at least one of the side walls having a cover panel integrally appended to it from a hinge score line, the cover panel has a flap extension for lapping a side wall other than the one side wall and is secured to it by a fuse bond between the inside surface coating of the polymer film on the flap extension and a selectively positioned area of the patterned solvent based polymer material on the outside surface of the other side wall.
Patent DE-69417142-D1 (DE)
Inventor: GERON JEAN
IPC: B62D1/10
Filed: 1994-10-14
Granted: 1999-04-22
Abstract: The steering wheel includes a central body (7) secured around its periphery to the coating (6) of the rim (1) and the spokes (2), as well as an outer layer (8) which continuously covers this coating (6) and the front face of the central body (7). The mounting piece (23) is a ring with an internal outline exhibiting two portions of a circle of different diameters and a binding screw. The steering column has a top, the end section (25) of which has a smaller diameter than the section (24) surrounded by the hub (3), and a groove at the base of the end section (25) in which the mounting piece (23) is accommodated. <IMAGE>
Patent DE-69417920-D1 (DE)
Inventor: SPEERT DAVID
IPC: A61P31/04
Filed: 1994-12-29
Granted: 1999-05-20
Abstract: Methods for reducing the risk of or preventing infections by bacterial pathogens in vivo. In particular, a method for reducing the risk of P. aeruginosa infection in vivo in compromised hosts such as cystic fibrosis patients. The methods involve the use of dextran or dextran sulphate as the active ingredient.
Patent DE-69424039-D1 (DE)
Inventor: BJOERK KARIN
IPC: C07D333/04
Filed: 1994-02-24
Granted: 2000-05-25
Abstract: PCT No. PCT/SE94/00152 Sec. 371 Date May 4, 1995 Sec. 102(e) Date May 4, 1995 PCT Filed Feb. 22, 1994 PCT Pub. No. WO94/19315 PCT Pub. Date Sep. 1, 1994   <IMAGE>  (I)  The present invention relates to novel derivatives of 3-hydroxyanthranilic acid, 3-HANA of general formula (I), wherein R1 and R2 are the same or different and selected from H and alkyl; X is selected from alkylthio, arylthio, aryloxy, halogen and cyano; R3, R4 are the same or different and selected from halogen, methyl, fluoroalkyl, cyano and Z-R5 wherein Z is selected from CHn, NHm, O, S, SO2 and CO wherein n=1 or 2; m=0 or 1 and R5 is selected from alkyl, aryl and fluoroalkyl; or R3 and R4 together form a saturated or unsaturated ring system Y-V-Z wherein Y and Z, independently of each other, are as defined for Z above and V is selected from C1-C3 alkylene or alkenylene, -N=, -N=N- and (a), wherein R7=H or alkyl; or a pharmaceutically acceptable salt thereof, methods and intermediates for their preparation, novel pharmaceutical compositions and the use thereof for inhibiting the enzyme 3-hydroxy-anthranilate oxygenase, 3-HAO, responsible for the production of the endogenous neurotoxin quinolinic acid, QUIN.
Patent DE-69428196-D1 (DE)
Inventor: HAUT E
IPC: B62B7/08
Filed: 1994-04-19
Granted: 2001-10-11
Abstract: A collapsable stroller for transporting a passenger includes a frame movable between a collapsed position and an operating position. The frame includes rotatably mounted wheels for providing the stroller with mobility. A passenger seat is provided for receiving the passenger. At least a portion of the passenger seat is movably mounted on the frame between a first position and a second position. A latch is mounted on the frame and the seat. The latch releasably holds the seat in the first position. The latch, seat and frame are configured such that when the seat is in the first position and the frame is moved from the operating position to the collapsed position, the latch automatically releases the seat and the seat moves to the second position.
Patent DE-69434020-D1 (DE)
Inventor: URBAN FRANK JOHN
IPC: A61K31/428
Filed: 1994-04-06
Granted: 2004-10-28
Abstract: A process for preparing the compound of the formula    <IMAGE>  I  which comprises treating a compound of the formula    <IMAGE>  II  wherein R2 is hydrogen, CN or CO2R1 and R1 is hydrogen or (C1-C6)alkyl with a reducing agent with the proviso that when R2 is CN or CO2R1 and R1 is (C1-C6)alkyl the product of the reduction is heated with an acid. Compounds of formula II wherein R2 is CN or CO2R1 and R1 is (C1-C6)alkyl or R2 is hydrogen and R1 is (C1-C6)alkyl or hydrogen. The compound of formula VII R1 is (C1-C6)alkyl. The compound of formula III. The compound of formula I is useful in the treatment of psychotic disorders.
Patent DE-69434871-D1 (DE)
Inventor: BRONSTEIN IRENA Y
IPC: C07F9/12
Filed: 1994-03-15
Granted: 2006-11-30
Abstract: Chemiluminescent bioassays for the presence or concentration of an analyte in a sample use 1,2-dioxetanes as substrates for the enzyme of an enzyme complex that bind to the analyte. The chemiluminescence obtained from the decomposition of the dioxetane triggered by the enzyme through the formation of the corresponding 1,2-dioxetane oxyanion of the enzyme complex is enhanced by the addition of TBQ as an enhancement agent. Other polymeric quaternary onium salts can be used as enhancement agents in conjunction with enhancement additives which improve the ability of the enhancement agent to form hydrophobic regions in the aqueous sample, in which regions the 1,2-dioxetane oxyanion and its chemiluminescent decomposition products can be sequestered. A kit for performing such assays is also provided.
Patent DE-69501927-D1 (DE)
Inventor: FOUREZON ANDRE
IPC: D04B21/16
Filed: 1995-07-17
Granted: 1998-05-07
Abstract: The textile fabric for use in a composite material, such as of a resin base such as polyester and others for use in moulds using pressure or injection or vacuum, has a layer (4) of synthetic fibres at least at one surface. The other layers (1-3) are stitched to the main layer (4) so that the layers (1-4) are all bonded together. Pref. The fibres of the fibre layer (4) are synthetic, significantly thinner than the other fibres in the composite fabric structure. The fibre layer (4) is a material with a weight of 50-150 g/m<2>, of polyester, with fibres of 1-7 dtex. <IMAGE>